BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24477403)

  • 1. Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis.
    Banisadr G; Schwartz SR; Podojil JR; Piccinini LA; Lanker S; Miller SD; Miller RJ
    J Neuroimmune Pharmacol; 2014 Jun; 9(3):438-45. PubMed ID: 24477403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis.
    Pyka-Fościak G; Lis GJ; Litwin JA
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
    Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
    Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis.
    Cohen ME; Fainstein N; Lavon I; Ben-Hur T
    Stem Cell Res; 2014 Sep; 13(2):227-39. PubMed ID: 25086214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
    Zilkha-Falb R; Kaushansky N; Kawakami N; Ben-Nun A
    J Neuroinflammation; 2016 Jan; 13():7. PubMed ID: 26747276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
    Gazitt Y; Akay C
    Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
    Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD
    J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.
    O'Boyle G; Mellor P; Kirby JA; Ali S
    FASEB J; 2009 Nov; 23(11):3906-16. PubMed ID: 19667120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow.
    Petty JM; Lenox CC; Weiss DJ; Poynter ME; Suratt BT
    J Immunol; 2009 Jan; 182(1):604-12. PubMed ID: 19109194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.
    Sanz-Rodríguez F; Hidalgo A; Teixidó J
    Blood; 2001 Jan; 97(2):346-51. PubMed ID: 11154207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
    van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
    J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions.
    Banisadr G; Podojil JR; Miller SD; Miller RJ
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):26-35. PubMed ID: 25997895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
    Gan Y; Liu R; Wu W; Bomprezzi R; Shi FD
    J Neuroimmunol; 2012 Jun; 247(1-2):9-15. PubMed ID: 22503411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis.
    McCandless EE; Wang Q; Woerner BM; Harper JM; Klein RS
    J Immunol; 2006 Dec; 177(11):8053-64. PubMed ID: 17114479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.
    Cheng M; Qin G
    Prog Mol Biol Transl Sci; 2012; 111():243-64. PubMed ID: 22917234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis.
    Kohler RE; Comerford I; Townley S; Haylock-Jacobs S; Clark-Lewis I; McColl SR
    Brain Pathol; 2008 Oct; 18(4):504-16. PubMed ID: 18422759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
    Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
    Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
    Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
    J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.